IPP Bureau
Rossari Biotech reviews capex, delays Unitop and Tristar expansion rollout
By IPP Bureau - April 24, 2026
The capacity addition to be implemented in a phased manner amid evolving business and market dynamics
Sai Life Sciences allots 2.44 lakh equity shares under employee stock option schemes
By IPP Bureau - April 24, 2026
Shares issued under ESOP 2008 and MESOP 2018 plans following exercise of vested stock options, in compliance with SEBI disclosure norms
Clariant boosts high-speed packaging efficiency with expanded continuous strip desiccant reels
By IPP Bureau - April 24, 2026
Extending production capabilities to the Americas helps reduce labor costs and inventory complexity for nutraceuticals and other industries while maintaining superior moisture control
Novo Nordisk posts strong late-stage results for oral diabetes pill in children and teens
By IPP Bureau - April 24, 2026
The study evaluated oral semaglutide in young patients with type 2 diabetes and found it delivered a superior reduction in HbA1c
Biocon receives Health Canada approval for Bosaya and Vevzuo biosimilars to Prolia and Xgeva
By IPP Bureau - April 24, 2026
Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
Shilpa Medicare appoints Dr Vellaian Karuppiah as COO – Formulations
By IPP Bureau - April 24, 2026
Veteran pharma leader brings 33+ years of experience to drive operational excellence in formulation business
K J Somaiya Hospital upgrades diagnostics with 1.5T MRI, NICU ventilators under Kotak Mahindra Bank CSR support
By IPP Bureau - April 24, 2026
The transition from an outsourced MRI model to an in-house facility marks more than an infrastructure upgrade
Gujarat Themis Biosyn to acquire anti-TB and anti-infective brands from Sanofi for EUR 158 Million
By IPP Bureau - April 24, 2026
Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence
Merck & Google Cloud ink $1 billion AI deal to build “Agentic” pharma future
By IPP Bureau - April 24, 2026
The collaboration will roll out an “agentic” AI platform across Merck’s research & development, manufacturing, commercial, and corporate operations
KIMS Hospitals Thane treats 88-Year-old PAD patient using advanced excimer laser atherectomy
By IPP Bureau - April 24, 2026
Minimally invasive laser-based procedure restores blood flow in complex arterial blockage, enables next-day discharge and improved mobility
ModeX doses first patients in trial of next-gen T-cell engager for aggressive B-cell lymphoma
By IPP Bureau - April 24, 2026
The investigational therapy, MDX2003, is designed to go after cancer cells with a multi-pronged immune attack
Boston Scientific surges into 2026 with double-digit sales growth & record quarterly profit jump
By IPP Bureau - April 24, 2026
Growth was broad-based across segments
Johnson & Johnson wins EU nod for next-gen surgical stapler
By IPP Bureau - April 24, 2026
The ETHICON 4000 Stapler and ETHICON 3D Reloads are now approved for use in both open and laparoscopic surgeries across the European Union
Philips bags FDA nod for next-gen CT platform
By IPP Bureau - April 24, 2026
Aims to boost speed & precision in patient care
_and_Dr__D_Nageshwar_Reddy_(AIG_Hospitals).jpg "Terumo India and AIG Hospitals partner to boost interventional radiology training and patient outcomes nationwide")
Terumo India and AIG Hospitals partner to boost interventional radiology training and patient outcomes nationwide
By IPP Bureau - April 23, 2026
The collaboration is designed to improve clinical outcomes, reduce procedural risks, and expand access to advanced image-guided treatments across a growing range of conditions
